Skip to main content
. 2022 Aug 19;13:975291. doi: 10.3389/fphar.2022.975291

FIGURE 2.

FIGURE 2

Cellular uptake of T7-siYY1-exo in vitro and BBB/BBTB model. (A) The delivery efficiency of Free siYY1 and T7-siYY1-exo in LN229 cells. Cy3-labeled siYY1 and loaded DID-labeled exosomes (5 μg/ml) were used to treat LN229 cells. After 24h incubation, the cytoskeleton was stained with phalloidin and the cell nuclei were stained with DAPI. The fluorescent was photographed under a confocal laser scanning microscope using Nikon NIS-Elements software (Nikon, Tokyo, Japan). (B) The knockdown efficiency of YY1 was detected by Western blot. (C) Schematic diagram of the BBB model in-vitro. (D) Representative immunofluorescence images showing T7-siYY1-exo uptake into LN229 cells after passing through a bEnd.3 monolayer. Unmod-exo/T7-siYY1-exo (5 μg/ml) was added to upper compartment. The fluorescent was photographed under a confocal laser scanning microscope using Nikon NIS-Elements software (Nikon, Tokyo, Japan). (E) The positive rates of DiD and Cy3 were detected by flow cytometry. (F,G) The penetrating and tumor targeting efficacy of T7-siYY1-exo evaluated through BBTB/LN229 tumor spheroids co-culture model. The treatment concentration of unmod-exo/T7-siYY1-exo was 5 μg/ml. The fluorescent was photographed under a confocal laser scanning microscope using Nikon NIS-Elements software (Nikon, Tokyo, Japan).